Stock HBMN HBM HEALTHCARE INVESTMENTS AG
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : HBM Healthcare Investments AG

Other languages HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Market Closed - Swiss Exchange
Other stock markets
 11:30:41 2023-12-08 am EST 		Intraday chart for HBM Healthcare Investments AG 5-day change 1st Jan Change
170 CHF -2.30% -2.86% -15.42%
Dec. 01 AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion MT
Nov. 21 Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation MT

Other languages

Search
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HBM Healthcare touche 39 millions de dollars grâce au rachat d'ImmunoGen
HBM Healthcare erhält 39 Millionen aus ImmunoGen-Übernahme
AbbVie erwirbt HBM-Portfoliounternehmen ImmunoGen für USD 10.1 Milliarden in bar
AbbVie erwirbt HBM-Portfoliounternehmen ImmunoGen für USD 10.1 Milliarden in bar
Aktien Schweiz von gestiegener Riskoneigung belastet
HBM Healthcare Investments Launches Share Buyback
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
HBM Healthcare Investments Logs Higher Fiscal H1 Loss
HBM Healthcare kauft trotz höherem Verlust Aktien zurück
HBM confirme sa perte nette au premier semestre 2022/23
HBM Healthcare Investments aktiviert Aktienrückkaufprogramm
HBM Healthcare Investments aktiviert Aktienrückkaufprogramm
HBM Healthcare Investments publiziert Halbjahresbericht per 30. September 2023 und Kennzahlen für das zweite Quartal des Geschäftsjahrs 2023/2024
HBM Healthcare Investments publiziert Halbjahresbericht per 30. September 2023 und Kennzahlen für das zweite Quartal des Geschäftsjahrs 2023/2024
HBM Healthcare Investments : Halbjahresbericht September 2023
HBM Healthcare Investments Flags Fiscal H1 Loss
HBM Healthcare anticipe une perte semestrielle de 70 millions
HBM Healthcare erwartet Verlust von 70 Millionen im Halbjahr
HBM Healthcare Investments publiziert inneren Wert je Aktie (NAV) von CHF 237.22 per 30. September 2023
HBM Healthcare Investments publiziert inneren Wert je Aktie (NAV) von CHF 237.22 per 30. September 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Announcement Date

Since

Until

  1. Stock
  2. Equities
  3. Stock HBM Healthcare Investments AG - Swiss Exchange
  4. News HBM Healthcare Investments AG
  5. Other languages
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer